Raj Asarpota

EVP, Chief Financial Officer

Raj Asarpota brings nearly 30 years of global executive leadership experience, including more than a decade as CFO of public and private life sciences and medical device companies. He was appointed Executive Vice President and Chief Financial Officer of Maravai LifeSciences in June 2025.

Raj joins Maravai with a strong track record of driving performance, advancing strategic initiatives, and scaling operations through organic growth and strategic acquisitions. Most recently, he served as EVP and CFO of Augmedics, a medical device company that develops augmented reality surgical navigation systems, with a focus on spine surgery, where he scaled commercial operations, raised capital, and led a strategic IP acquisition.

Previously, he was EVP and CFO of NuVasive, where he helped increase market capitalization by $1.2 billion and delivered significant margin expansion. He also served as CFO and COO of Cole-Parmer, where he led the company’s carve-out from Thermo Fisher Scientific. His earlier career includes key financial and operational leadership roles at Questcor Pharmaceuticals, Life Technologies, and GE Healthcare.

In his role at Maravai, Raj oversees the company’s global Finance, Accounting, Treasury, Investor Relations, Corporate Strategy, and Information Technology functions. Mr. Asarpota holds an MBA from Marquette University and a Bachelor of Commerce from the University of Mumbai.